Pulse News Wire translates Japanese corporate disclosures filed with the Tokyo Stock Exchange's TDNet system into clear, structured English for institutional investors, hedge funds, and asset managers. Every article on this page is derived directly from an official TDNet filing — including earnings reports, M&A announcements, share buybacks, dividend declarations, and governance changes. Japanese corporate governance is governed by the Companies Act and the Financial Instruments and Exchange Act; timely translation of these disclosures provides a material information advantage for cross-border investors monitoring Tokyo-listed equities.
This corporate disclosure was processed by Pulse News Wire. It represents a primary source document for Japanese equity sector intelligence, translated directly from an official filing submitted to the Tokyo Stock Exchange TDNet system.
ONO PHARMACEUTICAL CO.,LTD. Announces Officer Appointments
Source disclosure: March 02, 2026, 13:00 JST
Published by Pulse News Wire: March 02, 2026, 13:50 JST
ONO PHARMACEUTICAL CO.,LTD. [4528.T]
TOKYO, Mar 02 (Pulse News Wire) – ONO PHARMACEUTICAL CO.,LTD. (4528.T) has issued a disclosure regarding officer appointment.
The company disclosed details regarding changes to its board and executive management. For full details, please refer to the original disclosure document.
AI-translated content. 🟢 Confidence: High See terms • Origin
Source disclosure: March 02, 2026, 13:00 JST Published by Pulse News Wire: March 02, 2026, 13:50 JST
TOKYO, Mar 02 (Pulse News Wire) – ONO PHARMACEUTICAL CO.,LTD. (4528.T) has issued a disclosure regarding officer appointment.
The company disclosed details regarding changes to its board and executive management. For full details, please refer to the original disclosure document.
